Reimbursed with a limitationOriginator productATC B03XA02

Aranesp

Aranesp is an originator product from Amgen Switzerland AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 109.05 to CHF 1'385.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Amgen Switzerland AG
ATC code
B03XA02
IT group
06.07.30 Andere
Active substances
Darbepoetinum alfa
Preparation type
Originator product
On the SL since
01/11/2002
Last price change
01/06/2021
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Aranesp Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inj Lös 10 mcgFertspr 4 StkCHF 85.17CHF 109.0501/11/2002A7680557250047
Inj Lös 20 mcg m NadelschutzFertspr 4 StkCHF 169.11CHF 200.3501/11/2002A7680557250566
Inj Lös 30 mcg m NadelschutzFertspr 4 StkCHF 254.23CHF 292.9001/11/2002A7680557250580
Inj Lös 40 mcg m NadelschutzFertspr 4 StkCHF 337.49CHF 383.4501/11/2002A7680557250603
Inj Lös 50 mcg m NadelschutzFertspr 4 StkCHF 422.82CHF 476.2501/11/2002A7680557250627
Inj Lös 60 mcg m NadelschutzFertspr 4 StkCHF 507.62CHF 568.5001/11/2002A7680557250641
Inj Lös 80 mcg m NadelschutzFertspr 4 StkCHF 676.32CHF 751.9501/11/2002A7680557250665
Inj Lös 100 mcg m NadelschutzFertspr 4 StkCHF 843.40CHF 933.6501/11/2002A7680557250689
Inj Lös 150 mcg m NadelschutzFertspr 4 StkCHF 1'259.26CHF 1'385.9501/11/2002A7680557250702
Inj Lös 300 mcg m NadelschutzFertspr 1 StkCHF 628.29CHF 699.7001/07/2003A7680557250719
Inj Lös 500 mcg m NadelschutzFertspr 1 StkCHF 1'039.95CHF 1'147.4001/01/2004A7680557250733

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 17807.01Valid from 01/04/2022

Renale Anämie bei Niereninsuffizienz: 17807.01
Folgender Indikationscode ist an den Krankenversicherer zu übermitteln: 17807.01

FOPH wordingIndication 17807.02Valid from 01/04/2022

Behandlung der symptomatischen Anämie bei erwachsenen Tumorpatienten/innen mit einem Hämoglobinwert von Folgender Indikationscode ist an den Krankenversicherer zu übermitteln: 17807.02

FAQ

Is Aranesp covered by Swiss health insurance?

Yes, but only under conditions. Aranesp is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Aranesp cost in Switzerland?

The public price is the maximum price set by the FOPH and for Aranesp ranges from CHF 109.05 to CHF 1'385.95 per pack. The ex-factory price ranges from CHF 85.17 to CHF 1'259.26. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com